Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.61B 1.14B 1.02B 942M 853M 1.59B 109B 1.62B 11.23B 4.51B 57.09B 4.29B 4.2B 180B P/E 2026 *
19x
P/E 2027 * 13.8x
Enterprise Value 5.92B 890M 797M 733M 664M 1.24B 84.48B 1.26B 8.74B 3.51B 44.44B 3.34B 3.27B 140B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.3x
Free-Float
51.88%
Yield 2026 *
2.96%
Yield 2027 * 3.44%
1 day+2.16%
1 week+2.16%
Current month+23.60%
1 month+24.53%
3 months+14.32%
6 months+3.92%
Current year+3.03%
1 week 12.38
Extreme 12.38
13.45
1 month 10.67
Extreme 10.67
13.45
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 21/11/2023
President 60 24/11/2019
Director of Finance/CFO 44 21/11/2023
Director TitleAgeSince
Chairman 60 31/05/2009
Chairman 61 31/05/2009
Director/Board Member 44 15/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/05/26 Buy

Founder

1,359,000 0.3397%
12/05/26 Sell

Founder

-2,727,600 0.6818%
11/05/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+2.16%+2.16%-4.06%-40.82% 1.12B
+5.89%+0.32%-38.75%+6.57% 14.63B
+3.15%-0.82%-5.65%+0.27% 6.29B
+2.38%+2.45%-14.13%+4.15% 6.28B
+2.54%-0.70%-52.60%-39.12% 5.68B
-17.44%-25.30%-22.19%-39.02% 5.01B
+5.00%+3.16%+3.81%-5.08% 4.58B
+0.22%+6.79%-21.58%-35.68% 3.16B
+9.99%+10.71%+11.50%-15.30% 3.15B
+1.44%+5.67%-20.58%+33.86% 3.03B
Average +1.53%-1.32%-16.42%-13.02% 5.29B
Weighted average by Cap. +2.08%-3.07%-22.34%-7.95%

Financials

2026 *2027 *
Net sales 17.06B 2.56B 2.3B 2.11B 1.91B 3.58B 243B 3.64B 25.19B 10.11B 128B 9.62B 9.42B 404B 18.58B 2.79B 2.5B 2.3B 2.08B 3.89B 265B 3.97B 27.42B 11.01B 139B 10.48B 10.25B 440B
Net income 456M 68.54M 61.38M 56.46M 51.16M 95.63M 6.51B 97.42M 673M 270M 3.42B 257M 252M 10.8B 562M 84.46M 75.65M 69.58M 63.05M 118M 8.02B 120M 830M 333M 4.22B 317M 310M 13.3B
Net Debt -1.69B -253M -227M -209M -189M -353M -24.04B -360M -2.49B -998M -12.65B -950M -930M -39.88B -2.02B -304M -272M -251M -227M -424M -28.88B -432M -2.99B -1.2B -15.19B -1.14B -1.12B -47.91B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
29/10/26 CN¥13.25 +2.16% 17,347,980
29/10/26 CN¥12.97 +3.10% 18,100,200
28/10/26 CN¥12.58 -2.10% 13,644,600
27/10/26 CN¥12.85 -1.91% 9,412,400
26/10/26 CN¥13.10 +3.23% 16,585,949
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.25CNY
Average target price
13.19CNY
Spread / Average Target
-0.45%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock